Investment Committee Summary
| Rating | HOLD |
| Internal 5-tier | HOLD |
| Classification · conviction | quality defensive · medium |
| Evidence | 8/8 load-bearing inputs sourced |
| Triangulated fair value | $266 (-5% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $279 (-1% vs spot · 12m PWEV) |
| Next catalyst | 2026-11-01 — Capital-allocation / project-review update post activist pressure (portfolio high-grading) |
| Primary thesis-break | Industrial Gases organic volume growth (yoy) < 0.02 (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: HOLD
Internal 5-tier: HOLD · quality defensive · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $281 |
| Triangulated Fair Value | $266 (-5% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $279 (-1% vs spot · 12m PWEV) |
| Forward P/E | 19.5x |
| Market Cap | $63B |
| 52-Week Range | $229–$315 (intraday high and low over the trailing 52 weeks of the stock's own daily bars) |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across three weighted anchors — an intrinsic DCF, a scenario-weighted PWEV and a Monte Carlo median (Student-t + regime switching). Anchors are blended at fixed declared weights, each counted separately; the Monte Carlo, the scenario PWEV and the DCF's exit-multiple terminal all rest on the same base multiple, so where they agree it is partly by construction — not independent corroboration. Figures reconciled to Alpha Vantage 2026-10-09. Each chart below sits with the part of the thesis it evidences.
General research, published identically to every reader. Not personal financial advice. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Next catalyst |
|---|---|---|---|
| 49.7/100 (16th pct) | +1% 1yr expected | Hold | 20d — Capital-allocation / project-review update post activist pressure (portfolio high-grading) |
Full breakdown — conviction components, probability-return distribution, decision rules, factor & portfolio interaction and the catalyst timeline — in the Decision Support sections below. Model output for research; not personal financial advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: HOLD
Balanced: triangulated fair value $266 (-5% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Investment Thesis
At 293.18 (26 June 2026) APD trades on roughly 20.6 times forward earnings, a marked discount to Linde at 28.8 times. The market is paying for contracted compounding: the base target of 297.44 sits within two per cent of spot, so the shares already price the mid-cycle path. The engine is less generous. The probability-weighted target is 284.40, three per cent below spot, and the capex-bridge DCF anchors far lower at 201.28 on a 7.5 per cent WACC and a 17 times terminal multiple, because incremental ROIC of roughly 10 per cent barely clears the cost of capital. Monte Carlo puts only 34 per cent of outcomes above the current price, and the house view assigns 38 per cent to the industrial recession / de-rate state. HOLD follows: the franchise is real, but the price pays for it in full. The most damaging risk is FY2025 capex of 7.0 billion dollars (AV, 2025-09-30) earning sub-WACC returns into a demand rollover, against net debt of 17.4 billion.
The dashboard below is the whole argument on one page: spot ($281) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural bear is not a cyclical wobble. European chemicals and global steel, the core of on-site demand, are shedding capacity permanently, while the clean-hydrogen backlog that absorbed 13.8 billion dollars of capex across FY2024-25 (AV) still lacks committed, creditworthy offtake. If NEOM and Louisiana volumes cannot find buyers, APD carries rising depreciation on assets earning below the 7.5 per cent cost of capital, with 17.4 billion of net debt against 12.5 billion of revenue. Margins compress towards 26 per cent, growth turns negative, and the multiple de-rates from 20 towards 14 times as the market reclassifies APD from quality compounder to leveraged project developer. That path lands near 152, below the 52-week low of 226.03, and the market has not begun to price it.
Key Debate
P/E Multiple explains 72% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
What the Market Is Pricing In
At the current price, the market pays 19.5× consensus forward EPS, vs the house DCF terminal 16.0×, and a peer median 21.0×. The house DCF sits 6% below spot, so the market is pricing in more than the house case — roughly 0.6pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 13.5 | 13.2 | High |
| EPS | 14.4 | 14.4 | Medium |
| Target price | 343.5 | 270.2 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — Industrial De-Rating / Demand Shift' downside ($153) to a 'Bull — Multiple Re-Rate' bull case ($444); the probability-weighted blend (PWEV $279) is -1% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Industrial De-Rating / Demand Shift | 20% | $153 | -46% |
| Downturn — Industrial Recession | 18% | $231 | -18% |
| Base — Contracted Compounding | 34% | $297 | +6% |
| Growth — Clean-H₂ / Electronics Demand | 20% | $374 | +33% |
| Bull — Multiple Re-Rate | 8% | $444 | +58% |
| Probability-Weighted (PWEV, after SBC dilution) | — | $279 | -1% |
SBC charge: scenario targets are gross per-share prices; the PWEV is reduced by one year of stock-based-compensation dilution (1.5% of shares, on SBC ≈ 1% of revenue), trimming the gross PWEV of $284 to $279 (-1.5%). SBC is charged once, as dilution — never also deducted from FCF.
Scenario rationale — the driver path behind every target:
- Structural — Industrial De-Rating / Demand Shift (20%, $153). Structural impairment — industrial recession / clean-H₂ disappointment: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Downturn — Industrial Recession (18%, $231). Cyclical downturn — industrial-gas demand (steel/chem/electronics/healthcare) + clean-H₂ optionality weakens for 1–2 years before normalising.
- Base — Contracted Compounding (34%, $297). Mid-cycle — normalised industrial-gas demand (steel/chem/electronics/healthcare) + clean-H₂ optionality; disciplined capital allocation; steady returns.
- Growth — Clean-H₂ / Electronics Demand (20%, $374). Upside — electronics + clean-hydrogen build-out lifts earnings above mid-cycle; the multiple expands modestly.
- Bull — Multiple Re-Rate (8%, $444). Upside tail — sustained tight conditions or a structural re-rate on electronics + clean-hydrogen build-out.
Valuation Triangulation
Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the scenario PWEV, any DCF's exit-multiple terminal and any peer re-rate key off a market multiple, so they are not independent; only a DCF's explicit-period cash flows are multiple-free, and its terminal usually carries most of its value. The discipline is to read the spread, not to treat three numbers as three independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $249 | -12% | 20% (declared 15%) |
| Peer EV/Revenue re-rate | multiple | $74.62 | -73% | 0% — cross-check only |
| Scenario PWEV | multiple | $279 | -1% | 33% (declared 25%) |
| DCF (5-year + exit-multiple terminal) | cash flow + terminal × | $265 | -6% | 47% (declared 35%) |
| Triangulated (weighted) | — | $266 | -5% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way. The company-lever row in the Sensitivity section is an illustrative EBIT × multiple value, not a sum-of-parts anchor.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $249 and 35% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (72% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — explicit-period cash flows with an exit-multiple terminal
A 5-year cash-flow path discounted at a WACC of 7.5%, plus a terminal value of final-year FCF × 16.0x — a terminal multiple equal to 0.85 × the base multiple that the Monte Carlo and the scenario tree also use → $265. The terminal value is 73% of enterprise value, so this anchor moves with the multiple assumption. The heaviest anchor in this blend (47%); because its terminal is a market multiple, it is not independent of the multiple-driven anchors.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $74.62; the peer-median forward P/E is 21.0x, but the engine carries no P/E-implied price for this name (fewer than three same-sub-industry peers carry a forward multiple). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.
Across all anchors the spread is 77% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 11.2x | 13.6x | 16.0x | 18.4x | 20.8x |
|---|---|---|---|---|---|
| 5.5% | $212 | $253 | $294 | $336 | $377 |
| 6.5% | $201 | $240 | $279 | $318 | $358 |
| 7.5% | $190 | $227 | $265 | $302 | $340 |
| 8.5% | $180 | $215 | $251 | $287 | $322 |
| 9.5% | $170 | $204 | $238 | $272 | $306 |
DCF/share — revenue CAGR Δ × model op-margin Δ (Δ applied to the DCF's house margin path)
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $209 | $220 | $231 | $242 | $253 |
| -1.5pp | $224 | $236 | $247 | $259 | $271 |
| +0.0pp | $240 | $252 | $265 | $277 | $290 |
| +1.5pp | $257 | $270 | $283 | $297 | $310 |
| +3.0pp | $275 | $289 | $303 | $317 | $331 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Capex intensity ±15% | $221 | $309 | $87.00 |
| Terminal × ±15% | $227 | $302 | $75.00 |
| Revenue CAGR ±3pp | $231 | $303 | $72.00 |
| Model op margin ±3pp | $240 | $290 | $50.00 |
| WACC ±1pp | $251 | $279 | $28.00 |
Company lever — value at the base multiple vs Industrial Gases (on-site + merchant + packaged) multiple (base 20.0x)
| Multiple | 14.0x | 17.0x | 20.0x | 23.0x | 26.0x |
|---|---|---|---|---|---|
| Value at the base multiple (EBIT × multiple; illustrative, not a blend anchor) | $165 | $217 | $269 | $322 | $374 |
Illustrative: segment EBIT × multiple, plus net cash, over basic shares — it does not enter the triangulated fair value.
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| LIN | 28.8× | 6% | 28% | segment | 50% |
| NUE | 16.1× | 2% | 12% | direct | 100% |
| CTVA | 22.8× | 5% | 24% | direct | 100% |
| CRH | 19.1× | 6% | 0% | direct | 100% |
Quality-weighted forward P/E: 20.7× (simple median 21.0×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $229–$315, centre $269 (-4% vs spot); spot sits at the 61st percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV (FV ÷ price − 1) | $266 (-5% vs spot · triangulated FV) |
| Downside to lowest scenario (Structural — Industrial De-Rating / Demand Shift) | $153 (-46% vs spot · bear scenario) |
| Reward-to-risk ratio | withheld — the triangulated FV is at or below spot, so there is no reward leg to divide by the risk leg |
| Discount to fair value (1 − price ÷ FV) | -6% |
| P(price > spot) — Monte Carlo | 35% |
That ratio is (triangulated FV ÷ price − 1) ÷ (1 − 'Structural — Industrial De-Rating / Demand Shift' target ÷ price). 'Structural — Industrial De-Rating / Demand Shift' ($153, probability 20%) is the lowest-target scenario in the tree, taken gross of SBC dilution. With a leg missing the ratio is withheld rather than computed from a magnitude. Bull case (Bull — Multiple Re-Rate): $444.
Company Overview & Business Model
Air Products and Chemicals Inc — BASIC MATERIALS · SPECIALTY CHEMICALS. Air Products and Chemicals, Inc. is an American international corporation whose principal business is selling gases and chemicals for industrial uses. Air Products' headquarters is in Allentown, Pennsylvania.
Company description as supplied by Alpha Vantage; not checked against the company's filings.
How it makes money.
| Segment | Rev mix | Growth | Model op margin† | Key driver |
|---|---|---|---|---|
| Industrial Gases (on-site + merchant + packaged) | 100% | +6% | 31% | industrial-gas demand (steel/chem/electronics/healthcare) + clean-H₂ optionality |
† Model margin = gross margin − the opex ratio calibrated so the Monte Carlo median EPS meets the EPS target; it is not a reported operating margin.
Reported operating margin (GAAP): -7.3% for the fiscal year ended 2025-09-30; -4.7% TTM to 2026-06-30 (Alpha Vantage INCOME_STATEMENT).
Edge. Wide moat. Authored moat rationale withheld pending re-authoring.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Model op margin† | Model EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Industrial Gases (on-site + merchant + packaged) | $12.5B | 100% | 6% | 31% | $3.9B | 20.0x | 12% | ESTIMATE |
| † Model EBIT = revenue × the model margin, i.e. gross margin less the opex ratio the calibration solved for to meet the EPS target — not the company's reported operating income. |
For comparison, the company's reported GAAP operating margin was -7.3% for the fiscal year ended 2025-09-30; -4.7% TTM to 2026-06-30 (Alpha Vantage INCOME_STATEMENT).
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | industrial-gas demand (steel/chem/electronics/healthcare) + clean-H₂ optionality |
| net_debt_or_cash_b | -17.41 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.12 |
| div_yield | 0.0258 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | industrial recession / clean-H₂ disappointment |
| upside | electronics + clean-hydrogen build-out |
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $16.6B — highly levered |
| Net debt / EBITDA | 3.56x |
| Interest coverage (EBIT / interest) | -1.1x |
| Current ratio | 1.38x |
| Lease obligations | $0.7B |
| Cash & ST investments | $1.9B |
Balance-sheet data as of 2025-09-30 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $-3.8B |
| Buybacks / dividends | $0.0B / $1.6B |
| Total shareholder yield | 2.5% |
| Payout as % of FCF | -42.0% |
| Reinvestment (capex / OCF) | 216.2% |
| SBC as % of FCF | -2.0% |
| Allocation stance | reinvesting |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | -30.2% |
| FCF conversion (FCF / net income) | -75480.0% |
| FCF yield | -6.0% |
| Capex intensity (capex / revenue) | 56.2% |
| FCF − SBC (diagnostic) | $-3.9B |
| Capex split (maint / growth) | 35% / 65% — Capital-intensive builder in an active mega-project phase (clean-H2, on-site plants). Growth capex dominates and is the central debate — value-dilutive if returns disappoint; maintenance is the smaller steady-state slice. |
Accounting quality: SBC 1% of revenue.
Competitive Moat
Moat sources:
- 15-20 year take-or-pay on-site supply contracts with pass-through of energy/inflation — annuity-like cash flows
- Pipeline density and integrated hydrogen/industrial-gas networks (Gulf Coast) create local monopolies with high switching costs
- Capital scale and project-execution capability that a new entrant cannot match on merchant/on-site
- Caveat: mega-project (NEOM/clean-H2) execution risk and offtake uncertainty is a moat-adjacent liability, not a moat source
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q3): management +0.19 vs analyst floor +0.00 → delta +0.19 (n=31 mgmt / 20 Q&A; 7th pctile across the S&P book, z -1.4).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q3 | +0.19 | +0.00 | +0.19 |
| 2026Q2 | +0.37 | +0.00 | +0.37 |
| 2026Q1 | +0.15 | +0.02 | +0.13 |
| 2025Q4 | +0.31 | +0.15 | +0.16 |
News (last 365d, 1292 articles): avg ticker sentiment +0.20 (bullish 29% / bearish 6%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $343 (+22% vs spot · street) |
| House target | $270 (-21.3% vs street) |
| Sell-side coverage | 22 analysts (SB 4 / B 11 / H 7 / S 0 / SS 0; net score 0.43) |
| Consensus FY EPS | $14.44 (reference only — house values on EV/EBITDA) |
| Consensus FY revenue | $13.5B; house in-line (-1.9%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-11-01 (~23d) — Capital-allocation / project-review update post activist pressure (portfolio high-grading) (authored)
- 2026-11-05 (~27d) — Quarterly earnings — est. EPS $3.60 (AV EARNINGS_CALENDAR)
- 2027-06-30 (~264d) — NEOM green-hydrogen project construction / first-production milestone (authored)
Forecast Track Record
- EPS surprise: beat 88% of the last 8 quarters; average surprise +1.7%.
Catalyst Timeline
6 catalysts in the next 90 days (of 14 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-10-14 (in 2d) | September CPI | macro | ●● | 0.8 |
| 2026-10-28 (in 16d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-11-01 (in 20d) | Capital-allocation / project-review update post activist pressure (portfolio high-grading) | authored | ● | 0.7 |
| 2026-11-05 (in 24d) | Quarterly earnings | earnings | ●●● | 0.95 |
| 2026-12-09 (in 58d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 67d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-27 (in 107d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-03-17 (in 156d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 158d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 198d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-06-09 (in 240d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-06-18 (in 249d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-06-30 (in 261d) | NEOM green-hydrogen project construction / first-production milestone | authored | ● | 0.7 |
| 2027-09-17 (in 340d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Clean-hydrogen subsidy/tax-credit (45V, EU) rules and permitting for mega-projects | high (~55%) | medium — swings clean-H2 project returns, ~5-8% of FV | 12-24m |
| Carbon/emissions regulation and industrial-energy pricing | medium (~35%) | low-medium — largely contractually passed through, ~2-4% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Industrial De-Rating / Demand Shift | Structurally weaker industrial-production growth and a clean-H2 overbuild de-rate the industrial-gas group. | Stranded/low-return mega-project capex plus multiple compression hit book value and the multiple together. |
| Downturn — Industrial Recession | Global manufacturing recession cuts merchant/packaged volumes for 1-2 years (on-site is contracted). | Merchant volume/price weakness plus project-timing slippage strain free cash flow. |
| Base — Contracted Compounding | Long-term contracted backlog compounds mid-single-digits with pricing pass-through; disciplined project sanction. | Execution/timing on the large project backlog slips, delaying the earnings ramp. |
| Growth — Clean-H₂ / Electronics Demand | Clean-hydrogen offtake and electronics/semiconductor gas demand accelerate the growth pipeline at good returns. | Clean-H2 offtake fails to firm and returns fall below cost of capital, making growth value-dilutive. |
| Bull — Multiple Re-Rate | Successful capital discipline and de-risked projects earn APD a re-rate toward the Linde multiple. | Re-rate is contingent on execution APD has repeatedly missed; disappointment reverses it fast. |
Decision Rules (Machine-Checked)
Stance: Hold — 0 bullish / 0 bearish / 1 caution rules triggered of 5 evaluable (1 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
-3.92 | no |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
-3.92 | no |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.43 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
no data | — |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
0.99 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
1.59 | YES |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is what the model's own rules read on this name; it does not modify the published research rating, and it is not personal financial advice.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Industrial Gases organic volume growth (yoy) < 0.02 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Adjusted operating margin < 0.3 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Large-project impairment or cancellation charge (clean-hydrogen backlog) >= USD 0.5B single charge (single event). (rationale withheld pending re-authoring — frozen figure or verdict)
- FY capital expenditure guidance > USD 6.0B (single event). (rationale withheld pending re-authoring — frozen figure or verdict)
- FY adjusted EPS guidance < 13.85 (single event). Midpoint of the base scenario EPS (14.85) and the Downturn EPS (12.85). A guide below this line means price, volume or project contribution is failing and the earnings bridge to the base target is broken.
Fact / Inference / Speculation
- FACT: Spot $281; 52-week range $229–$315; engine rating HOLD; house target $270 (-4%). (source: Alpha Vantage 2026-10-09, 12 October 2026)
- INFERENCE: Triangulated FV $266 (-5% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the DCF anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
49.7/100 (confidence band 35.6–63.9), 16th percentile of 893 covered names (as of 2026-10-10). Weighted composite under config ros-1.20.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 28 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | 16 | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 46 | 15% | upside_pct |
| growth | 54 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 88 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 87 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 32 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | — | 10% | industry_context.house |
| risk profile | 60 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.
Score history: 49.6 → 49.8 → 50.2 → 50.3 → 49.1 → 49.4 → 49.5 → 49.3.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — Industrial De-Rating / Demand Shift | 20% | $153 | -45.6% | -9.1pp |
| Downturn — Industrial Recession | 18% | $231 | -17.8% | -3.2pp |
| Base — Contracted Compounding | 34% | $297 | +5.6% | +1.9pp |
| Growth — Clean-H₂ / Electronics Demand | 20% | $374 | +33.0% | +6.6pp |
| Bull — Multiple Re-Rate | 8% | $444 | +57.7% | +4.6pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | +0.8% |
| Expected return net of SBC dilution | -0.7% |
| Outcome dispersion (σ, from MC p10–p90) | 28.2% |
| Expected Sharpe (rf 4%) | -0.11 |
| Downside expectation (prob-weighted loss branches) | -12.3% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | 0.8% |
| Risk-free rate | 4.49% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-10-08) |
| Beta (shrunk, 1y vs SPY) | 0.45 (as of 2026-10-09) |
| Equity risk premium | 4.5% |
| Required return | 6.5% |
| Expected alpha | -5.7% |
| Alpha per unit risk (EA/σ) | -0.20 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 31.1% (1σ) | 23.0% implied | broadly consistent with the market's implied uncertainty |
| Mass above spot: scenarios vs our own MC | 62.0% | 34.7% | the scenario weights and the MC parameters disagree about our OWN view — this is a model-coherence issue, not a market disagreement |
| Realised scenario frequency | 58 dated anchors | — | 58 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $283.51.
Flagged for review: internal coherence (authored mass vs Monte Carlo). A flag marks a disagreement worth understanding — it does not imply either side is wrong.
Factor Exposures
Cross-sectional percentiles over 928 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 67 | AI | 24 | |
| Value | 28 | Cloud | 12 | |
| Quality | 14 | Semis | 35 | |
| Momentum | 51 | Consumer | 15 | |
| Low-Vol | 96 | Rates | 8 | |
| USD | 78 | |||
| Energy | 93 |
Market interaction: correlation vs SPY +0.32, vs QQQ +0.21 (trailing ~1y daily returns).
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies -1% vs spot
- Monte Carlo median implies -12% vs spot
- DCF fair value (exit-multiple terminal) implies -6% vs spot — but this is terminal-value sensitive (exit-multiple $265 vs Gordon $335, 26% apart), so it carries less weight
- Bear case (Structural — Industrial De-Rating / Demand Shift) downside is -46% vs spot
- Net: the valuation anchor itself sits 5.3% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Model Appendix
DCF — line items
| Year | Revenue | Op income (house path) | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $13B | $4B | $5B | $7B | $5B | $5B |
| FY+2 | $14B | $5B | $5B | $6B | $5B | $5B |
| FY+3 | $15B | $5B | $4B | $6B | $5B | $4B |
| FY+4 | $15B | $5B | $4B | $5B | $5B | $4B |
| FY+5 | $16B | $5B | $4B | $5B | $5B | $3B |
| Terminal | — | — | — | — | $5B × 16.0x | $56B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 12% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 7.5% · Σ PV(FCF) $21B + PV(terminal) $56B = EV $77B; − net debt $17.4B → equity $59B ÷ diluted shares $0.22B = $265/share (exit-multiple terminal).
- Gordon terminal → $335/share — a single-point perpetual-growth cross-check at g = 2.5% (one growth rate, not a range; it is not in the blend).
- Incremental ROIC on the forecast capex ≈ 4% vs WACC 7.5% → below WACC — the incremental build is value-dilutive.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| LIN | 7.5x | 28.8x | 6% | 28% |
| NUE | 1.8x | 16.1x | 2% | 12% |
| CTVA | 3.1x | 22.8x | 5% | 24% |
| CRH | 2.4x | 19.1x | 6% | -0% |
| Median | 2.7x | 21.0x | — | — |
Implied prices at the peer medians: EV/Rev → $74.62 (no P/E-implied price — fewer than three same-sub-industry peers carry a forward multiple).
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $265 | 47% | $124 |
| Scenario PWEV | $279 | 33% | $93.11 |
| Monte Carlo median | $249 | 20% | $49.72 |
| Triangulated | — | 100% | $266 |
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 7.5% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 16× | DCF exit value | house rule (0.85 × base multiple) |
| Terminal growth | 2.5% | Gordon cross-check (single point) | estimate |
| SBC dilution | 1.5%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Capex intensity ±15% (87.0); Terminal × ±15% (75.0); Revenue CAGR ±3pp (72.0); Model op margin ±3pp (50.0); WACC ±1pp (28.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $12.5B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $13.2B | company guidance | Company guidance | Medium | Forecast, SoP |
| FY+1 guided EPS | $14.4369 | company guidance | Company guidance | Medium | Forward P/E, scenarios |
| Consensus FY EPS | $14.4403 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.224B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $16.55B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 7.5% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 16× | house estimate | House rule: 0.85 × the base multiple (shared with the Monte Carlo) | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | Gordon cross-check (single point, not in the blend) |
| SBC dilution | 1.5%/yr | house estimate | From SBC/revenue | Medium | PWEV, MC, DCF (charged once) |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.20.0 |
| Analysis as-of | 2026-10-12 (prices 2026-10-09) |
| Narrative authorship | claude_code, drafted 2026-07-06 |
| Human review | engine output reviewed at the estate level, not name-by-name |
| Evidence | 8/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF: WACC 7.5%, terminal multiple 16×, FY+5 revenue $16B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-10-09 | Price, market cap, EV, forward P/E | Alpha Vantage 2026-10-09 |
| MCH engine — trailing 52 weeks of daily bars | derived | 2026-10-09 | 52-week range (intraday high and low over the trailing year of the stock's own daily bars) | trailing 52 weeks of own daily bars (intraday high/low, 2025-10-10 to 2026-10-09, 251 sessions) |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-10-09 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-10-09 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-10-09 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-10-09 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-10-09 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-10-09 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-10-09 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-10-09 | Segment revenue and multiple; model margin = gross margin − the calibrated opex ratio (not a reported margin) | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-10-09 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-10-09 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personal financial advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Analysis quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.